I thought for a long time Phylogica would do better as a private company BDM had the right idea last year. Delist continue pushing forward outside of the spotlight then list again floating saying 10% of the company on a foreign index a year or two later with a new value.
Talking about spin-offs though what happened with Phenomica ? Supposedly surrounded by partners / venture funds that wanted a bite ? yet 3 years later ? ?
The thing is if Endosomal Escape is supposedly successful then what's it really saying about it if Janssen don't move to license or acquire the company / technology but would rather "spin it off" ?
I thought for a long time Phylogica would do better as a private...
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.010(5.26%) |
Mkt cap ! $933.2M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 20.0¢ | 18.8¢ | $963.9K | 4.978M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2692 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 445208 | 3 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| PYC (ASX) Chart |